# WEILL MEDICAL COLL OF CORNELL UNIV: Human(h) HCN1-Selective Nanobodies for use in the Development of Novel, Non-Opioid Antihyperalgesics for the Treatment of Neuropathic Pain

**Lab Budget Score:** 55/100

| Field | Value |
|---|---|
| Organization | WEILL MEDICAL COLL OF CORNELL UNIV |
| Location | NEW YORK, NY |
| Project | Human(h) HCN1-Selective Nanobodies for use in the Development of Novel, Non-Opioid Antihyperalgesics for the Treatment of Neuropathic Pain |
| Project number | 1R61NS147892-01 |
| Mechanism | R61 |
| Institute | National Institute of Neurological Disorders and Stroke |
| Award | $635,074 |
| Awarded | 2026-08-28 |
| Project period | 2026-09-01 to 2028-08-30 |
| UEI | YNT8TCJH8FQ8 |

## Why this score
- Award of $400K or more.
- Research or center grant: supplies, instruments and services budget.

Source: NIH RePORTER (newly awarded projects) (https://reporter.nih.gov/project-details/11329911). Last refreshed: 2026-11-04T21:37:56.465Z.
Award data comes from NIH RePORTER and may be revised by NIH. Organization-level only; investigator names and contacts are not included. Informational only.